Capital Fund Management »

Halozyme Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9M 72k 40.68
2023-09-30 $2.7M 72k 38.20
2023-06-30 $1.9M 53k 36.07
2016-09-30 $2.5M 205k 12.08
2016-03-31 $587k 62k 9.47
2015-12-31 $4.4M 253k 17.33
2015-09-30 $4.2M 313k 13.43
2013-06-30 $149k 19k 7.93